Sponsor:
Southeast Retina Center, Georgia
Code:
NCT02976012
Conditions
Proliferative Diabetic Retinopathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Aflibercept
Endolaserless Vitrectomy
Brief summary:
Conditions
Proliferative Diabetic Retinopathy
Study ID
NCT02976012
Start date
Jun, 2016
Status verified date
Nov, 2016
Completion date
Jun, 2018
Anticipated
Primary completion date
Jun, 2018
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
24 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: IAI q8 week Group
active comparator: IAI q16 week Group
Interventions
Aflibercept
Endolaserless Vitrectomy
Primary outcome measure
Central contacts
Locations
Southeast Retina Center, PC
Recruiting
Augusta, Georgia, United States, 30809
Contacts
Siobhan Ortiz
706-650-0061Sponsor
Southeast Retina Center, Georgia
Last update posted
Nov 29, 2016
Last verified
Nov, 2016
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Southeast Retina Center, Georgia on 2016-11-29.